Establishment of immune complex-mediated disease models by human patient sera
| Project/Area Number |
22590885
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Kidney internal medicine
|
|---|
| Research Institution | Nagoya University |
|---|
Principal Investigator |
TSUBOI Naotake 名古屋大学, 医学部附属病院, 講師 (50566958)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
YUZAWA Yukio 藤田保健衛生大学, 医学部, 教授 (00191479)
MARUYAMA Shoichi 名古屋大学, 大学院・医学系研究, 准教授 (10362253)
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | 好中球 / 全身性ループスエリテマトーデス / インテグリン / Fc 受容体 / Fc受容体 / 自己免疫疾患 / 免疫複合体 / Fcγ受容体 |
|---|
| Research Abstract |
In newly established animal model of lupus nephritis induced by passive transfer of human systemic lupus erhythematosus (SLE) sera, essential role of human FcγRIIA and protective role of Mac-1 for disease induction were elucidated. The Pristine-induced SLE model demonstrated dual roles of Mac-1 as promoting pulmonary hemorrhage and as protective against lupus nephritis.
|
Report
(4 results)
Research Products
(89 results)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Asymptomatic diverticulosis identified by computed tomography is not a risk factor for enteric peritonitis2011
Author(s)
Toda S, Ito Y, Mizuno M, Suzuki Y, Ito I, Hiramatsu H, Ozaki T, Tsuboi N, Sato W, Maruyama S, Imai E, Matsuo S
-
Journal Title
Nephrol.Dial.Tranplant.
Volume: 27(6)
Issue: 6
Pages: 2511-6
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
